fda glp-1 news november 2025 The has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing glp-1 news updates november 2025

Eli Lilly might have solved that problem with orforglipron, a small-molecule formulation.

The microbiome-to-hormone signaling pathway is real

(3) Further, research says that mold dampens glutathione levels, so if you take it in supplement form, you might boost your bodys natural defense system

As with any new medication, there is more to learn to ensure patients are set up for success

This is not uncommon

Insurance coverage will be a challenge if not expanded to include other conditions, one physician said, so FDA approval is paramount. This challenge echoes concerns of patients, who also list high costs as the primary obstacle to GLP-1RA treatment, according to The Cure GLP-1RA Report: Insights from Patients on GLP-1RA Medications and the Future of Obesity Treatment, which reports results of a survey of patients who had taken GLP-1RA medications